^™middle.

Gathering signals...

Adheris Health (ASX:AHE) — Material Events

ASX:AHE · 3 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed

Significant Score 75–89

1

Adheris Health Targets Over 30% Cost Savings by FY27 with AI-Driven StrategyMedium

Adheris Health extends cost savings target to 30%+ by FY27, refocuses on high-growth pharma categories and digital innovation

2 Feb 2026 ·Non-Deal Roadshow Presentation ·75

Notable Score 50–74

2

Adheris Health Secures $6.1m Holdback, Total ANZ Sale Proceeds Hit $33.1mMedium

Adheris Health receives A$6.1m holdback payment post ANZ divestment, total proceeds now A$33.1m

27 Jan 2026 ·ASX Release ·70

Adheris Health Slashes Costs Amid 46% Revenue Drop, Eyes Digital GrowthMedium

Adheris Health Q2 FY26 revenue down 46%, new CEO drives cost cuts and digital platform launch

30 Jan 2026 ·Quarterly Activities Report and Appendix 4C ·70

Not Assessed Low Score, or missing data

0

No articles in this tier for the last 12 months.

Market Mentions 1 - appeared in market wrap coverage

These are market wrap articles where Adheris Health (ASX:AHE) was mentioned. They reflect broader market coverage, not company-specific announcements.

Healthcare Wrap - Week 6 (2 Feb -> 6 Feb) 2026